Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Lymphatic Mapping of Second Echelon Lymph Nodes With Methylene Blue

NCT01823172 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01823172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01823172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Lymphatic Mapping of Second Echelon Lymph Nodes With Methylene Blue
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
November 30, 2013
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, melanoma